BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8198375)

  • 1. Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus.
    King GL; Shiba T; Oliver J; Inoguchi T; Bursell SE
    Annu Rev Med; 1994; 45():179-88. PubMed ID: 8198375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Basal membrane and diabetes mellitus].
    Masmiquel L; Burgos R; Simó R
    Med Clin (Barc); 1997 Sep; 109(8):302-10. PubMed ID: 9379754
    [No Abstract]   [Full Text] [Related]  

  • 3. [The significance of compensation in diabetes mellitus in the development of diabetic microangiopathies (a review of the literature)].
    Gendeleka GF
    Vrach Delo; 1989 Aug; (8):54-8. PubMed ID: 2686158
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers.
    Ban CR; Twigg SM
    Vasc Health Risk Manag; 2008; 4(3):575-96. PubMed ID: 18827908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Damage to the vascular endothelium of diabetic patients can be assessed by analysing blood samples for the number of circulating endothelial cells with mitochondrial DNA deletions.
    Egawhary DN; Swoboda BE; Chen J; Vince FP
    Biochem Soc Trans; 1995 Aug; 23(3):402S. PubMed ID: 8566290
    [No Abstract]   [Full Text] [Related]  

  • 6. The vascular complications of diabetes mellitus.
    Gnudi A; Lugari R
    Acta Biomed Ateneo Parmense; 1995; 66(3-4):119-24. PubMed ID: 8578928
    [No Abstract]   [Full Text] [Related]  

  • 7. The microvascular complications of early diabetes in the Pima Indians.
    Bennett PH; Miller M
    Adv Metab Disord; 1973; 2():Suppl 2:401-13. PubMed ID: 4720378
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperglycemia and microangiopathy. Direct regulation by glucose of microvascular cells.
    Kreisberg JI
    Lab Invest; 1992 Oct; 67(4):416-26. PubMed ID: 1434526
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese Type 2 diabetic subjects.
    Matsuda M; Kawasaki F; Yamada K; Kanda Y; Saito M; Eto M; Matsuki M; Kaku K
    Diabet Med; 2004 Aug; 21(8):881-8. PubMed ID: 15270792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.
    Barrett EJ; Liu Z; Khamaisi M; King GL; Klein R; Klein BEK; Hughes TM; Craft S; Freedman BI; Bowden DW; Vinik AI; Casellini CM
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4343-4410. PubMed ID: 29126250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and microangiopathy.
    Szalat A; Raz I
    Isr Med Assoc J; 2006 Jun; 8(6):424-5. PubMed ID: 16833174
    [No Abstract]   [Full Text] [Related]  

  • 12. Relation of diabetic control to development of microvascular complications.
    Tchobroutsky G
    Diabetologia; 1978 Sep; 15(3):143-52. PubMed ID: 359393
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of angiogenic growth factors in the development of diabetic complications].
    Siebert J; Reiwer-Gostomska M
    Kardiol Pol; 2009 Jan; 67(1):62-4. PubMed ID: 19253193
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic control and the late complications of diabetes.
    Gerich JE
    Am Fam Physician; 1977 Aug; 16(2):85-91. PubMed ID: 888756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetic microangiopathy--its biochemical bases].
    Kawazu S; Tomono S
    Nihon Rinsho; 1991 Feb; 49 Suppl():34-42. PubMed ID: 1827848
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetic microvascular complications and growth factors.
    Pfeiffer A; Schatz H
    Exp Clin Endocrinol Diabetes; 1995; 103(1):7-14. PubMed ID: 7621107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biochemistry of the complications of diabetes mellitus.
    Brownlee M; Cerami A
    Annu Rev Biochem; 1981; 50():385-432. PubMed ID: 6168237
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperglycemia and angiogenesis].
    Larger E; Seno di Marco G
    Journ Annu Diabetol Hotel Dieu; 2005; ():11-25. PubMed ID: 16161301
    [No Abstract]   [Full Text] [Related]  

  • 19. Basement membrane abnormalities in diabetes mellitus: relationship to clinical microangiopathy.
    Williamson JR; Tilton RG; Chang K; Kilo C
    Diabetes Metab Rev; 1988 Jun; 4(4):339-70. PubMed ID: 3292174
    [No Abstract]   [Full Text] [Related]  

  • 20. Endothelin inhibition delays onset of hyperglycemia and associated vascular injury in type I diabetes: evidence for endothelin release by pancreatic islet beta-cells.
    Ortmann J; Nett PC; Celeiro J; Traupe T; Tornillo L; Hofmann-Lehmann R; Haas E; Frank B; Terraciano LM; Barton M
    Biochem Biophys Res Commun; 2005 Aug; 334(2):689-95. PubMed ID: 16009335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.